Iron supplement for anemia in heart disease patients
Part of Blood & lymphatic, Heart & circulation, Hormones & metabolism clinical trials.
This study follows patients with mild to moderate iron deficiency anemia who also have heart disease. It tests a specific iron supplement (Ferretab Comp.) that is taken twice a day to see how it affects their anemia, without adding any extra procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been diagnosed with mild to moderate iron deficiency anemia (based on recent blood tests: hemoglobin and ferritin levels).
- You have heart disease, such as coronary artery disease or heart failure with preserved ejection fraction (HFpEF).
- You have not taken iron supplements or iron-containing medications in the past 3 months.
- You are not pregnant or breastfeeding.
- You do not have severe health conditions like advanced kidney disease, severe liver disease, active cancer, or recent bleeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving intravenous iron improves symptoms, quality of life, and exercise ability in people with heart failure and low iron levels. Participants will receive iron infusions and be monitored over time to see if their condition improves.
This trial tests a single dose of intravenous iron given after heart surgery to see if it helps prevent or reduce long-term anemia. It is for adults who already have low iron or anemia before surgery and who remain anemic the day after surgery.
This study checks how common iron deficiency is in people with HFpEF (heart failure with preserved pumping strength) and tests whether an iron infusion (Ferinject®) improves health. It targets people with stable heart symptoms and lab results showing low iron stores or related iron deficiency.
This study tests whether intravenous (IV) iron therapy can help older adults who have heart failure with preserved pumping function and low iron levels. It aims to improve symptoms and quality of life.
This study tests whether intravenous iron can improve outcomes for people with non-ischemic heart failure and low ejection fraction who are also iron deficient. If you fit the criteria, you may receive iron infusions to see if it helps your heart function and symptoms.
This study compares two different doses of IV iron (low vs high) to see which works better for people with heart failure and low iron levels. It may help you feel less tired and breathe easier.
Hear when a new Iron Deficiency Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.